Literature DB >> 3169116

The cardiovascular effects of nebulized adenosine in man.

M O Coupe1, B Clarke, A Robson, P J Oldershaw, P J Barnes.   

Abstract

We have studied the cardiovascular effects of inhaled adenosine in healthy subjects. Adenosine at a concentration of 5 mg.ml-1 is absorbed and produces an increase in heart rate of 6-7 beats per min, blood pressure and skin temperature being unaltered. The rise in heart rate is less than that seen with an infusion of a comparable dose and is unlikely to be adequate for therapeutic termination of supraventricular tachycardia. Higher doses are limited by the poor solubility of adenosine. Inhalation as a method of delivering adenosine has possibilities as an alternative route of administration, but some practical problems remain to be overcome.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3169116     DOI: 10.1007/bf00615231

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  7 in total

Review 1.  The action of purines on human airways.

Authors:  S T Holgate; M J Cushley; J S Mann; P Hughes; M K Church
Journal:  Arch Int Pharmacodyn Ther       Date:  1986-04

2.  Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects.

Authors:  M J Cushley; A E Tattersfield; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1983-02       Impact factor: 4.335

3.  Adenosine-sensitive ventricular tachycardia: evidence suggesting cyclic AMP-mediated triggered activity.

Authors:  B B Lerman; L Belardinelli; G A West; R M Berne; J P DiMarco
Journal:  Circulation       Date:  1986-08       Impact factor: 29.690

4.  Rapid and safe termination of supraventricular tachycardia in children by adenosine.

Authors:  B Clarke; J Till; E Rowland; D E Ward; P J Barnes; E A Shinebourne
Journal:  Lancet       Date:  1987-02-07       Impact factor: 79.321

5.  Controlled hypotension with adenosine in cerebral aneurysm surgery.

Authors:  A Sollevi; M Lagerkranser; L Irestedt; E Gordon; C Lindquist
Journal:  Anesthesiology       Date:  1984-10       Impact factor: 7.892

6.  Dipyridamole inhibition of adenosine metabolism in human blood.

Authors:  R E Klabunde
Journal:  Eur J Pharmacol       Date:  1983-09-16       Impact factor: 4.432

7.  Cardiovascular effects of infused adenosine in man: potentiation by dipyridamole.

Authors:  T B Conradson; C M Dixon; B Clarke; P J Barnes
Journal:  Acta Physiol Scand       Date:  1987-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.